ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 118 filers reported holding ERASCA INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,000 | +17.4% | 13,549 | +61.0% | 0.00% | – |
| Q2 2023 | $23,000 | +91.7% | 8,418 | +108.2% | 0.00% | – |
| Q1 2023 | $12,000 | -62.5% | 4,044 | -45.0% | 0.00% | – |
| Q4 2022 | $32,000 | +433.3% | 7,349 | +827.9% | 0.00% | – |
| Q3 2022 | $6,000 | +200.0% | 792 | +116.4% | 0.00% | – |
| Q2 2022 | $2,000 | -99.3% | 366 | -98.9% | 0.00% | – |
| Q1 2022 | $279,000 | +316.4% | 32,442 | +653.6% | 0.00% | – |
| Q4 2021 | $67,000 | +36.7% | 4,305 | +85.7% | 0.00% | – |
| Q3 2021 | $49,000 | – | 2,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 11,055,554 | $21,779,441 | 14.15% |
| EDBI Pte Ltd | 888,888 | $1,751,109 | 1.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,926,000 | $3,794,220 | 1.28% |
| Cormorant Asset Management, LP | 10,813,246 | $21,302,095 | 1.24% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $615,625 | 0.64% |
| Artal Group S.A. | 4,721,194 | $9,301 | 0.40% |
| PFM Health Sciences, LP | 3,930,633 | $7,743,347 | 0.36% |
| ARMISTICE CAPITAL, LLC | 8,356,000 | $16,461,320 | 0.25% |
| SANDERS MORRIS HARRIS LLC | 425,297 | $816,569 | 0.17% |
| Prosight Management, LP | 264,710 | $521,479 | 0.16% |